Breaking News: Quoin Pharmaceuticals Sets Price for $6.8 Million Public Offering in 2024

Quoin Pharmaceuticals Ltd. Announces Pricing of Public Offering About Quoin Pharmaceuticals Ltd. Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) is a clinical stage, specialty pharmaceutical company that focuses on rare and orphan diseases. The company is dedicated to developing innovative solutions to help patients with these challenging conditions. Public Offering Details On December 20, 2024, Quoin Pharmaceuticals…

Read More

Vanda Pharmaceuticals Receives Orphan Drug Designation for VGT-1849A: A Promising Treatment for Polycythemia Vera

Vanda Pharmaceuticals Receives Orphan Drug Designation for VGT-1849A in Treatment of Polycythemia Vera Introduction Washington, Dec. 20, 2024 – Vanda Pharmaceuticals Inc. (Vanda) has recently made groundbreaking strides in the treatment of polycythemia vera (PV) with the announcement of the U.S. Food and Drug Administration (FDA) granting Orphan Drug Designation for VGT-1849A. This selective antisense…

Read More

Breaking News: Monopar Therapeutics Inc. Drops Mic with $40 Million Public Offering and Private Placement Shenanigans!

Getting Warm and Cozy with Monopar Therapeutics Inc. Catching up on the Latest News Did you hear the latest scoop? Monopar Therapeutics Inc., a biotechnology company that always keeps us on our toes, has just announced some big news that has the medical community abuzz. They’ve priced an underwritten registered offering of their common stock,…

Read More

Eightco Successfully Secures Non-Dilutive Capital and Extends Debt for Second Time

$7.2 Million Debt Extension and $3.1 Million New Financing to Fuel Expansion Plans for 2025 Eightco Holdings Inc. Announces Debt Restructuring and New Financing Easton, PA, Dec. 20, 2024 (GLOBE NEWSWIRE) — Eightco Holdings Inc. (NASDAQ: OCTO) (the “Company” or “Eightco”) today announced that its wholly-owned subsidiary, Forever 8 Fund, LLC (“Forever 8”), completed a…

Read More

Proactive Investors: Your Source for Professionally Educated, Profit-Focused, and Intense Company News

Giyani Metals Corp Provides Update on Demonstration Plant Commissioning Introduction Giyani Metals Corp (TSX-V:EMM, OTC:CATPF) has recently provided an update on the commissioning of its Demonstration Plant (Demo Plant) in Johannesburg, South Africa, as part of its K.Hill battery-grade manganese project in Botswana. The company has announced that the plant is nearing completion of commissioning,…

Read More

Get Ready to Say Buh-Bye to Boring Business News: Banzai Scoops Up Vidello, Boosting Revenue and EBITDA Like a Boss!

Banzai Expands Portfolio with Vidello Acquisition A Match Made in Marketing Heaven Dec. 20, 2024 – SEATTLE, WA Have you ever felt the struggle of creating engaging video content for your business? Well, fear no more because Banzai International, Inc. is here to save the day! The marketing technology company has just announced its acquisition…

Read More